Cefotaxime, Ceftriaxone and Ceftazidime injection ranges (currently in CP Pharmaceuticals livery) are about to enter the market in Wockhardt’s new safer packaging design

Our new packaging is designed with patient safety in mind and has been commended by the NPSA & the National QC Committee

 

Key safety enhancements include:

§ Market leading innovation – Tall Man lettering used to aid product differentiation

§ Clearer font style and larger font sizes­­

§ Colour used to differentiate between product ranges and strengths

§ Route of administration clearly displayed on front of pack

§ Safety enhancements duplicated on vial labels

§ Minimal corporate branding

                

                                                                                                 

 For further information on the product range, please see the related documents